Global Pharmacogenomics Market 2025–2029: Competitive Insights and Opportunities

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Pharmacogenomics Industry Expected To Reach By 2029, Starting From 2025 Levels?

The overall scale of the pharmacogenomics industry has seen swift expansion lately, projected to increase from a value of $8.94 billion in the year 2024 up to $9.84 billion by 2025, reflecting a compound annual growth rate (CAGR) of 10.0%. This upward trajectory observed during the past period is largely owing to robust economic expansion within developing regions, a heightened emphasis on tailoring medical treatments to individual profiles, enhancements in sophisticated medical support systems, and greater spending allocated to healthcare services.

Anticipated for swift expansion, the pharmacogenomics realm is projected to achieve a valuation of $14.53 billion by 2029, propelled by a compound annual growth rate (CAGR) registering at 10.2%; this upward trajectory through the projection timeframe is fueled by several factors, notably the expanding elderly demographic, the prevalence of persistent ailments, the general population increase, and heightened requirements for oncology interventions. Current significant shifts shaping this market encompass the deployment of genome editing technologies enabling more profound scrutiny of sophisticated treatments, a heightened emphasis on incorporating artificial intelligence for interpreting genetic datasets, progress in metagenomic research methodologies, mutual agreements and joint ventures between key industry entities, the advent of three-dimensional genomics techniques for investigating factors impacting gene activity and operation, novel product introductions concentrating on areas like infectious conditions and gene manipulation, alongside the creation of pharmacogenomic screening tools specifically for psychiatric medications intended to support better-informed choices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7072&type=smp

Which Drivers Are Shaping The Pharmacogenomics Industry’s Market Share?

The increasing need for personalized healthcare solutions is fueling growth within the pharmacogenomics sector. Precision medicine represents an advanced approach to healthcare that advocates for tailoring medical choices, therapeutic interventions, procedures, or products to specific patient groups, moving away from standardized, universal regimens. This growing preference for precision medicine is largely spearheaded by its significant advancements in oncology, though its promising utility is also expanding into other areas like rare and inheritable conditions. Fundamentally, the objective of precision medicine involves synthesizing an individual’s genetic makeup and environmental data to better understand specific illnesses and/or their reactions to various therapies. To illustrate this trend, an analysis from Linchpinseo in March 2022 indicated that major pharmaceutical corporations are projected to raise their financial commitments to precision medicine by one-third over the subsequent five years. Moreover, in the United States, where annually 30 million individuals receive diagnosis and care for Type 2 Diabetes, precision medicine offers the potential to deliver customized treatment plans, thereby reshaping established care protocols. Consequently, the expanding adoption of precision medicine initiatives will serve as a primary catalyst for the pharmacogenomics market expansion.

What Are The Major Segments Identified In The Pharmacogenomics Market?

The pharmacogenomicsmarket covered in this report is segmented –

1) By Technology: Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies

2) By Application: Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications

3) By End User: Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users

Subsegments:

1) By Next Generation Sequencing (NGS): Whole Genome Sequencing, Targeted Sequencing, Exome Sequencing

2) By Polymerase Chain Reaction (PCR): Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR

3) By Gel Electrophoresis: Agarose Gel Electrophoresis, Polyacrylamide Gel Electrophoresis, Capillary Gel Electrophoresis

4) By Mass Spectrometry: LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry), MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight), HRMS (High-Resolution Mass Spectrometry)

5) By Microarray: SNP Microarrays, Expression Microarrays, Comparative Genomic Hybridization (CGH) Arrays

6) By Other Technologies: Sanger Sequencing, CRISPR-Based Technologies, Bioinformatics Tools

Which Key Trends Are Expected To Influence The Pharmacogenomics Market In The Coming Years?

A significant driver propelling growth in the pharmacogenomics sector is the rapid stride of technological progress. Pharmaceutical developers are concentrating on diverse strategies for pharmacogenomics assessment, aiming to deliver economical methods both for identifying established genetic variations and uncovering new mutations. As an illustration, in May of 2022, Invitae, a laboratory service provider based in the United States, introduced an enhanced version of its Pharmacogenomics Panel. This panel, which incorporates the Mental Health Panel, offers crucial data regarding how individuals genetically react to drugs across several medical fields, such as general practice, heart health, and cancer treatment. Considering that approximately one quarter of the patient population experiences unusual drug reactions influenced by their genetic makeup, pharmacogenomics testing is poised to transition into routine medical procedure; successful incorporation into patient care necessitates bolstering the resources available to clinicians to comprehend and utilize PGx testing within their day-to-day clinical environments.

Who Are The Key Multinational Companies Dominating The Pharmacogenomics Market?

Major companies operating in the pharmacogenomics market include Illumina Inc, Eurofins Scientific, Myriad Genetics Inc, PerkinElmer Inc, Centogene N.V, Invitae Corporation, Genomind, Pacific Biosciences of California Inc, Oneome LLC, Admera Health, MapMyGenome, Positive Bioscience, Xcode Life Sciences, Xcelris Labs, Takeda Pharmaceutical Company Limited, Garvan Institute of Medical Research, 3D Medicines Inc, Berry Genomics, BGI, GenomiCare Biotechnology, Bayer AG, GlaxoSmithKline plc (GSK), F Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V, Centro de Genoma e Biologia de Sistemas (CGBS), Dasa Group, Datar Cancer Genetics Limited, MedGenome Labs, 23andMe, Color Genomics, Pathway Genomics, Laboratório Richet, Laboratório Exame, Genomika Diagnósticos

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

How Does The Pharmacogenomics Market Perform Across Key Geographic Regions?

North America was the largest region in the pharmacogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pharmacogenomics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7072&type=smp

Browse Through More Reports Similar to the Global Pharmacogenomics Market 2025, By The Business Research Company

Point Of Care Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Molecular Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795